C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2608333
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the CDKs, Aurora, Jak2, Rock, CAMKII, FLT3, Tie2, TrkB, FGFR3 and KDR kinases.
L'invention concerne une nouvelle classe de composés, compositions pharmaceutiques comprenant de tels composés ainsi que des procédés d'utilisation pour traiter ou prévenir des maladies ou des troubles associés à l'activité anormale ou déréglée de la kinase, plus spécifiquement des maladies ou troubles mettant en oeuvre l'activation anormale de CDKs, Aurora, Jak2, Rock, CAMKII, FLT3, Tie2, TrkB, FGFR3 et KDR kinases.
Gray Nathanael S.
Okram Barun
Ren Pingda
Fetherstonhaugh & Co.
Irm Llc
The Scripps Research Institute
LandOfFree
Pyrrolopyridine derivatives as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolopyridine derivatives as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyridine derivatives as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1914518